Figure - available from: Advanced Materials
This content is subject to copyright. Terms and conditions apply.
CLSM images of fixed HeLa cells stained by DAPI (blue) with DTIBT‐NCs (red, A) and rod‐like TIBT‐NRs (red, B). CLSM image of fixed HeLa cells stained by DAPI (blue) with spherical TIBT‐NCs (red, C), and CLSM image of these cells in (C) after 5 days of preservation (D). CLSM image of living HeLa cells stained by DTIBT‐NCs (E–I) and TIBT‐NCs (J–N) within 5 days. Fluorescence images of HeLa cells stained with DCFH‐DA and DTIBT‐NCs (O,R), TIBT‐NRs (P,S), or TIBT‐NCs (Q,T) treated in darkness (O–Q) and under light irradiation (400–800 nm, 10 mW cm⁻², 5 min; R–T). Cell viability of 4T1 cells treated by DTIBT‐NCs, TIBT‐NRs, or TIBT‐NCs in the presence and absence of white light irradiation (400–800 nm, 140 mW cm⁻², 5 min; U). Data are shown as mean ± SD (n = 5).

CLSM images of fixed HeLa cells stained by DAPI (blue) with DTIBT‐NCs (red, A) and rod‐like TIBT‐NRs (red, B). CLSM image of fixed HeLa cells stained by DAPI (blue) with spherical TIBT‐NCs (red, C), and CLSM image of these cells in (C) after 5 days of preservation (D). CLSM image of living HeLa cells stained by DTIBT‐NCs (E–I) and TIBT‐NCs (J–N) within 5 days. Fluorescence images of HeLa cells stained with DCFH‐DA and DTIBT‐NCs (O,R), TIBT‐NRs (P,S), or TIBT‐NCs (Q,T) treated in darkness (O–Q) and under light irradiation (400–800 nm, 10 mW cm⁻², 5 min; R–T). Cell viability of 4T1 cells treated by DTIBT‐NCs, TIBT‐NRs, or TIBT‐NCs in the presence and absence of white light irradiation (400–800 nm, 140 mW cm⁻², 5 min; U). Data are shown as mean ± SD (n = 5).

Source publication
Article
Full-text available
To enhance the phototheranostic performance, agents with high reactive oxygen species (ROS) generation, good tumor‐targeting ability, and prolonged retention are urgently needed. However, symmetric donor–acceptor (D–A) type agents usually produce spherical nanoaggregates, leading to good tumor targeting but inferior retention. Rod‐like nanoaggregat...

Similar publications

Article
Full-text available
Ovarian cancer accounts for more deaths than any other female reproductive tract cancer. The major reasons for the high mortality rates include delayed diagnoses and drug resistance. Hence, improved diagnostic and therapeutic options for ovarian cancer are a pressing need. Extracellular vesicles (EVs), that include exosomes provide hope in both dia...